KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLoans and Notes ReceivablesLong-Term Debt IssuancesNon-Current ReceivablesReceivables RefundsShares OutstandingShares Repurchased
Ratios

Royalty Pharma (RPRX) Shares Outstanding (2020 - 2025)

Historic Shares Outstanding for Royalty Pharma (RPRX) over the last 6 years, with Q4 2025 value amounting to $428.7 million.

  • Royalty Pharma's Shares Outstanding fell 388.26% to $428.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $428.7 million, marking a year-over-year decrease of 388.26%. This contributed to the annual value of $428.7 million for FY2025, which is 388.26% down from last year.
  • As of Q4 2025, Royalty Pharma's Shares Outstanding stood at $428.7 million, which was down 388.26% from $429.0 million recorded in Q3 2025.
  • Over the past 5 years, Royalty Pharma's Shares Outstanding peaked at $451.0 million during Q1 2024, and registered a low of $392.9 million during Q1 2021.
  • For the 5-year period, Royalty Pharma's Shares Outstanding averaged around $436.9 million, with its median value being $439.1 million (2022).
  • In the last 5 years, Royalty Pharma's Shares Outstanding skyrocketed by 1670.05% in 2021 and then tumbled by 563.02% in 2025.
  • Over the past 5 years, Royalty Pharma's Shares Outstanding (Quarter) stood at $433.0 million in 2021, then rose by 2.36% to $443.2 million in 2022, then rose by 0.8% to $446.7 million in 2023, then dropped by 0.16% to $446.0 million in 2024, then dropped by 3.88% to $428.7 million in 2025.
  • Its last three reported values are $428.7 million in Q4 2025, $429.0 million for Q3 2025, and $432.3 million during Q2 2025.